Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 2a, Proof-of-Concept Study of ASP8302 in Subjects With Underactive Bladder
Conditions
Interventions
ASP8302
Placebo
Locations
29
Germany
Site DE49001
Duisburg, Germany
Site DE49002
Duisburg, Germany
Site DE49004
Gronau, Germany
Site DE49003
Mönchengladbach, Germany
Site JP81009
Nagoya, Aichi-ken, Japan
Site JP81008
Ōbu, Aichi-ken, Japan
Start Date
November 20, 2018
Primary Completion Date
April 28, 2020
Completion Date
April 28, 2020
Last Updated
November 21, 2024
NCT06956209
NCT06753071
NCT05576311
Lead Sponsor
Astellas Pharma Europe B.V.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions